In ovarian cancer and myeloproliferative neoplasm, PBX1 has been shown to participate in maintaining cancer stem cell-like phenotypes and promoting platinum resistance, at least partially, through its intricate interaction with the JAK2/STAT3 signaling network [16,19]. The gene discussed is STAT3; the disease is cancer.